News & Updates
Filter by Specialty:
Show Multimedia Only

Lorundrostat for uncontrolled hypertension hits efficacy, safety targets in phase III trial
10 Jul 2025
byJairia Dela Cruz
Twelve weeks of treatment with the aldosterone synthase inhibitor lorundrostat proved efficacious and safe for lowering blood pressure (BP) in adults with uncontrolled hypertension, including those who were resistant to treatment, according to the phase III Launch-HTN trial.